Upcoming Themed Issues:
CTS Late 2024: Diversity, Equity, and Inclusion (DEI)
Clinical and Translational Science (CTS) is inviting submissions for a special collection on Diversity, Equity, and Inclusion (DEI) that is scheduled for initial, rolling publication in the late 2024. This collection is dedicated to evaluating the impact of diversity, equity, and inclusion (DEI) on advancing clinical pharmacology. We consider age, race, sexual orientation, genders, abilities, disabilities, protected classes, religions, cultures and other protected classes as meeting our definition of DEI. Submissions of original research are particularly encouraged, but reviews, position/white papers or perspectives from regulatory agencies, academia, societies, and industry are also welcome. Educational, tutorial-style papers will also be considered. Click here for more info.
To be considered for publication in this high-profile themed issue, manuscripts should be submitted via the online submission and tracking system by December 31, 2024.
PSP Fourth Quarter 2025: Model-Based Innovations in Pediatric Rare Disease
CPT: Pharmacometrics and Systems Pharmacology (PSP) inviting submissions for a special themed issue on Model-Based Innovations in Pediatric Rare Disease scheduled for publication in the 4th quarter of 2025. This special issue will showcase the application of pharmacometrics and systems pharmacology research innovation in the development of therapeutics and advances in understanding disease progression for pediatric rare diseases. Original research articles are encouraged. Submissions may also include reviews/mini-reviews, tutorials, position/white papers, PSP case reports, and perspectives from regulatory agencies, academia, societies, and industry. Click here for more info.
To be considered for publication in this themed issue, manuscripts should be submitted via the online submission and tracking system by May 15, 2025.
CTS: Mechanism of Action Mini Reviews
Clinical and Translational Science (CTS) is inviting submissions for a special collection on Mechanism of Action Mini Reviews. CTS’s “Mechanism of Action Mini Reviews” demystify these complex agents and modalities, from mechanism to development and regulatory journey to clinical impact. For practitioners, pharmacists, and researchers, these mini reviews offer a concise yet comprehensive understanding of new therapeutics. For patients and the general public, they provide insights into how these drugs can manage or cure diseases, enhancing informed healthcare decisions. Click here for more info.